Evidence-based management of premenstrual syndrome

European Clinics in Obstetrics and Gynaecology

Volumn 2, Issue 2, 2006, Pages 65-71

  Thangaratinam, Shakila ^a   Ismail, K ^a   O'Brien, S ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Evidence based management; Medical treatment; Premenstrual syndrome; Surgical management

Indexed keywords

EID: 33748124826     PISSN: 16133412     EISSN: 16133420     Source Type: Journal    
DOI: 10.1007/s11296-006-0031-z     Document Type: Review

References (55)

1. IPSOS (1999) A survey to establish the awareness and opinions regarding severe PMS (PMDD) in five European countries. RSL
2. Frank RT (1931) The hormonal causes of premenstrual tension. AMA Arch Neurol Psych 26:1053
3. Chakmakjian ZH (1983) A critical assessment of therapy for the premenstrual tension syndrome. J Reprod Med 28:532-538
4. O'Brien PMS (1982) The premenstrual syndrome: A review of the present status of therapy. Drugs 24:140-151
5. Dalton K (1984) The premenstrual syndrome and progesterone therapy, 2nd edn. Yearbook Medical, Chicago IL
6. Wyatt K, Dimmock P, Jones P et al (2001) Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systematic review. BMJ 323:776-780
7. Freeman EW, Kroll R, Rapkin A et al (2001) Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Women's Health Gend-based Med 21:561-569
8. Yonkers KA, Brown C, Pearlstein TB et al (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492-501
9. de Lignieres B, Vincens M, Mauvais-Jarvis P et al (1986) Prevention of menstrual migraine by percutaneous oestradiol. BMJ 293:1540
10. Watson NR, Studd JW, Savvas M et al (1989) Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 2:730-732
11. Deeny M, Hawthorn R, McKay HD (1991) Low dose danazol in the treatment of the premenstrual syndrome. Postgrad Med J 67:450-454
12. Hahn PM, Van Vugt DA, Reid RL (1995) A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 20:193-209
13. O'Brien PMS, Abukhalil IEH (1999) Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase only danazol. Am J Obstet Gynecol 180:18-23
14. Sarno APJ, Miller EJJ, Lundblad EG (1987) Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 70:33-36
15. Watts JF, Butt WR, Logan ER (1987) A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 94:30-34
16. Taskin O, Gokdeniz R, Yalcinoglu A et al (1998) Placebo-controlled crossover study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod 13:2402-2405
17. Di Carlo C, Palomba S, Tommaselli GA et al (2001) Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 75:380-384
18. Wyatt K, Dimmock P, Ismail KMK et al (2004) The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: A meta analysis. BJOG 111:585-593
19. Dodin S, Lemay A, Maheux R et al (1991) Bone mass in endometriosis patients treated with GnRH implant or danazol. Obstet Gynecol 7:410-415
20. Studd J, Leather AT (1996) The need for addback with gonadotrophin-releasing hormone agonist therapy. Br J Obstet Gynaecol 103(Suppl 14):1-4
21. Mortola JF, Girton L, Fischer U (1991) Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 71:252A-252F
22. Hammarback S, Backstrom T, Holst J et al (1985) Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 64:393-397
23. Leather AT, Studd JWW, Watson NR, Holland EFN (1999) The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: A placebo-controlled study. Gynecol Endocrinol 13:48-55
24. Andersch B (1983) Bromocriptine and premenstrual symptoms: A survey of double blind trials. Obstet Gynecol Surv 38:643-646
25. Ylostalo P, Kauppila A, Puolakka J et al (1982) Bromocriptine and norethisterone in the treatment of premenstrual syndrome. Obstet Gynecol 59:292-298
26. Graham JJ, Harding PE, Wise PH et al (1978) Prolactin suppression in the treatment of premenstrual syndrome. Med J Aust 2:18-20
27. Kullander S, Svanberg L (1979) Bromocriptine treatment of the premenstrual syndrome. Acta Obstet Gynecol Scand 58:375-378
28. Rapkin AJ, Morgan M, Goldman L et al (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90:709-714
29. Dimmock P, Wyatt K, Jones P, O'Brien PMS (2000) Efficacy of selective serotonin re-uptake inhibitors in premenstrual syndrome: A systematic review. Lancet 356:1131-1136
30. Halbreich U, Bergeron R, Yonkers KA et al (2002) Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 100:1219-1229
31. Hussain SY (1994) The compartmental distribution of fluid and electrolytes in relation to the symptomatology of the ovarian cycle and premenstrual cycle. Ph.D. thesis, University of London
32. Burnet RB, Radden HS, Easterbrook EG et al (1991) Premenstrual syndrome and spironolactone. Aust N Z J Obstet Gynaecol 31:366-368
33. Hellberg D, Claesson B, Nilsson S (1991) Premenstrual tension: A placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate. Int J Gynaecol Obstet 34:243-248
34. Wang M, Hammarback S, Lindhe BA et al (1995) Treatment of premenstrual syndrome by spironolactone: A double-blind, placebo-controlled study. Acta Obstet Gynecol Scand 74:803-808
35. Budoff PW (1987) Use of prostaglandin inhibitors in the treatment of PMS. Clin Obstet Gynecol 30:453-464
36. Facchinetti F, Fioroni L, Sances G et al (1989) Naproxen sodium in the treatment of premenstrual symptoms: A placebo-controlled study. Gynecol Obstet Invest 28:205-208
37. Jakubowicz DL, Godard E, Dewhurst J (1984) The treatment of premenstrual tension with mefenamic acid: Analysis of prostaglandin concentrations. Br J Obstet Gynaecol 91:78-84
38. Mira M, McNeil D, Fraser IS et al (1984) Mefenamic acid in the treatment of premenstrual syndrome. Obstet Gynecol 68:395-398
39. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1999) Differential response to antidepressants in women with premenstrual syndrome/ premenstrual dysphoric disorder: A randomized controlled trial. Arch Gen Psychiatry 56:932-939
40. Freeman EW, Rickels K, Sondheimer SJ et al (1995) A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274:51-57
41. Pearlstein TB, Stone AB, Stone AB et al (1997) Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 17:261-266
42. Stevinson C, Ernst E (2001) Complementary/alternative therapies for premenstrual syndrome: A systematic review of randomized controlled trials. Am J Obstet Gynecol 185:227-235
43. Wyatt K, Dimmock P, Jones P, O'Brien PMS (1999) Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review. BMJ 318:1375-1381
44. Taskin O, Gokdeniz R, Yalcinoglu A et al (1998) Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod 13:2402-2405
45. Budeiri D, Li Wan Po A, Dornan JC (1996) Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 17:60-68
46. Vaddadi KS (1981) The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins Med 6:375-379
47. Arlane M (1986) The use of a cognitive restructuring intervention in the treatment of premenstrual syndrome: A controlled study. Diss Abstr Int 47:381
48. Corney RH, Stanton R (1990) Comparison of progesterone, placebo and behavioural psychotherapy in the treatment of premenstrual syndrome. J Psychosom Obstet Gynaecol 11:211-220
49. Morse C, Dennerstein L, Farrell E (1991) A comparison of hormone therapy, coping skills training and relaxation for the relief of premenstrual syndrome. J Behav Med 14:469-489
50. Taylor D (1999) Effectiveness of professional-peer group treatment: symptom management for women with PMS. Res Nurs Health 22:496-511
51. Lemos D (1991) The effects of aerobic training on women who suffer from premenstrual syndrome. Diss Abstr Int 52:563
52. Bibi KW (1995) The effects of aerobic exercise on premenstrual syndrome symptoms. Diss Abstr Int 56:6678
53. Metcalf MG, Braiden V, Livesey JH et al (1992) The premenstrual syndrome: Amelioration of symptoms after hysterectomy. J Psychosom Res 36:569-584
54. Osborn M, Gath D (1990) Psychological and physical determinants of premenstrual symptoms before and after hysterectomy. Psychol Med 20:565-572
55. Cronje WH, Vashisht A, Studd JWW (2004) Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 19:2152-2155